In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.
--------
Question: Verifying Authority and Legality In Drug Compounding Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) with respect to the regulation of compounding drugs.

Eliminates authority for compounding pharmacies to: (1) compound drugs before the receipt of a valid prescription order, or (2) compound any drug product that is a copy of a commercially available drug.

Requires the Secretary of Health and Human Services (HHS) to develop, maintain and transmit to the appropriate state agencies a list of drug products that should not be compounded, including: (1) drug products whose compounding is reasonably likely to cause an adverse effect on their safety or effectiveness; and (2) drug products that have been withdrawn or removed from the market because they have been found to be unsafe or not effective.

Authorizes the Secretary to waive the requirement that a drug product must be compounded for an individually identified patient based on a valid prescription order or similar notation if compounding the drug product is necessary to address a drug shortage, or to protect public health or well-being. Prohibits the Secretary from authorizing a state to grant such waivers.

Authorizes the Secretary to waive the requirement that a drug product must be compounded for an individually identified patient based on a valid prescription order or similar notation if the pharmacy or pharmacist: (1) submits a satisfactory application to the Secretary; and (2) agrees to comply with any condition or limitation specified by the Secretary. Makes a pharmacy or pharmacist required to be registered under the FFDCA as a drug producer ineligible for a waiver. Permits the Secretary to authorize a state to grant such waivers applicable to compounded drug products sold or dispensed within the state pursuant to a memorandum of understanding between the Secretary and the state.

Authorizes the Secretary to waive the prohibition against compounding any drug product that is a copy of a commercially available drug if it is necessary to protect public health or well-being. Prohibits the Secretary from authorizing a state to waive such prohibition.

Subjects the facilities of any pharmacy receiving a waiver under this Act to inspection to determine compliance with this Act.

Requires the Secretary to publish notice at least 30 days before cancelling a waiver, unless it is necessary to prevent an adverse impact on public health or safety.

Sets forth a required label statement for any drug compounded pursuant to this Act.

 Requires a pharmacist or physician compounding a drug product to report any adverse event associated with the use of the product within a specified time frame.

Answer: To amend the Federal Food, Drug, and Cosmetic Act to provide for the compounding of drug products.


Question: Authorizes the Secretary, acting through the Director of the Agency, to establish a program under which funding will be provided for at least 15 demonstration projects to be competitively awarded in health care facilities and organizations in geographically diverse locations to determine the causes of medical errors and develop specified methods to reduce, minimize, and provide for reporting and corrective action of, such errors. Provides that at least five of such projects shall require participating health care providers to report adverse events and health- or medication-related errors to the patient and patient's family member. Permits the use of reported information only for purposes of evaluating the ability to reduce errors in delivery of care. Subjects such information to confidentiality requirements and makes it inadmissible as evidence in any civil or criminal action. Prohibits disclosure of such information under the Freedom of Information Act as well.
Directs the Secretary to: (1) provide for establishment of a national database of medical errors to contain information collected under this Act; (2) provide information to educate patients and family members about their role in reducing medical errors; (3) develop programs that encourage patients to take a more active role in their medical treatment; and (4) make grants to health professional associations and other organizations to provide training in ways to reduce medical errors.
Requires the Secretary to report to appropriate congressional committees on: (1) costs associated with implementing a program that identifies factors that contribute to errors and which includes upgrading the heath care computer systems and other technologies in the United States to reduce medical errors; and (2) the success of each demonstration project, data collected by States, best methods for reducing medical errors and costs associated with applying such methods, and sharing information on best practices to reduce such errors in Federal health care programs.
Authorizes appropriations.

Answer: Medical Error Reduction Act of 2000


Question: Timber-Dependent Counties Stabilization Act of 1999 - Revises the existing rate for State sharing of Forest Service and Bureau of Land Management timber sale receipts through a specified date, and permits States to choose either rate after such date.

Answer:
Timber-Dependent Counties Stabilization Act of 1999